Aimovig, a ground-breaking drug to prevent Migraines was approved by the FDA last week. Aimovig will be the only player in the market to treat migraines. The new drug has to be taken once a month through an injection similar to an insulin shot or an EpiPen.
Antibiotics play a major role in the medical field in order to eliminate the pathogens. Nowadays, the overutilization of antibiotics seems to be an upcoming disaster which not only leads to pollution via pharmaceutical wastes, but it had also increased the risk of antibiotic resistance.
Pulmonary hypertension is an acute lung disease which affects the right side of the heart, leading to increased blood pressure in the arteries of the lungs, since the artery walls become thickened. Research work is going on worldwide to discover the ultimate therapy for pulmonary hypertension.
A research team led by Dr. Gerhard Walzl from Stellenbosch University in South Africa, has discovered a new blood test to predict tuberculosis development up to two years before its onset in high-risk patients. In the study, the expression level of four genes named “RISK4”, associated with inflammatory response, were measured.
More than one-quarter of the world’s population were constantly getting affected with the one of the world’s oldest and deadliest disease named Tuberculosis (TB). In spite of 6-9 months antibiotic therapy, it’s very difficult to treat tuberculosis. That’s why researchers throughout the world were trying to find the faster ways of cure.
Previous research on color blindness correction was conducted using gene therapy, while EnChroma developed sunglasses which could correct the issue. But they were bulky and expensive, and could not be used with regular corrective lenses.
In the pilot phase, individual grants would be provided which would range from $250,000 to $2 million over two years. An additional $10 million may be provided if project is promising in animal studies but that money won’t be the part of this funding round
The company announced that the innovative product, whose technological details are not known yet, is undergoing clinical trials in five cities across the world. The patent-pending invention is based on open standards software and cloud-based analytics. The system gives users real-time notifications and cloud-based AI solutions.
Rabies takes nearly 60,000 lives each year; it is deadly if not treated early. Regions like Africa and Asia are at higher risk. LN34 is believed to make screening faster and better test to avoid the weeks-long series of shots now given to prevent the disease for the people exposed to potentially rabid. The test, done on suspect animals, can be run on platforms which are already used to screen for the flu, tuberculosis, and HIV.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.